ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.72
0.00%
US Tech 100
20,620.80
-1.35%
S&P 500
5,881.99
-1.49%
US Dollar vs CAD
1.44031
-0.01%
Bitcoin
92,229.58
-1.38%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Biodesix Inc (BDSX) Share Price

Biodesix Inc

Biodesix Inc (BDSX)

NASDAQ
1.48
0.02
(1.37%)
Closed December 27 3:00PM
Delayed by 15 minutes
1.48
0.00
( 0.00% )
Pre Market: 8:28AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
1.48
Bid
1.50
Ask
1.54
Volume
50
0.00 Day's Range 0.00
1.11 52 Week Range 2.21
Market Cap
215.292M
Previous Close
1.48
Open
-
Last Trade
25
@
1.54
Last Trade Time
07:49:23
Financial Volume
-
VWAP
-
Average Volume (3m)
423,536
Shares Outstanding
145,467,295
Dividend Yield
-
PE Ratio
-4.13
Earnings Per Share (EPS)
-0.36
Revenue
49.09M
Net Profit
-52.15M

About Biodesix Inc

Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic researc... Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
www.biodesix.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Biodesix Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker BDSX. The last closing price for Biodesix was US$1.48. Over the last year, Biodesix shares have traded in a share price range of US$ 1.11 to US$ 2.21.

Biodesix currently has 145,467,295 shares outstanding. The market capitalization of Biodesix is US$215.29 million. Biodesix has a price to earnings ratio (PE ratio) of -4.13.

Ask ADVFN Intelligence (AI)

BDSX Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

November 22 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 13 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 13 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 13 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 13 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 13 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

November 12 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

November 12 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

November 12 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

November 12 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.06-3.89610389611.541.571.41991641621.47071836CS
40.042.777777777781.441.611.2152587801.39468801CS
12-0.22-12.94117647061.71.721.114235361.34121719CS
26-0.04-2.631578947371.522.041.112748281.44030566CS
52-0.29-16.3841807911.772.211.112114661.49187628CS
156-2.66-64.25120772954.145.99730.9551967431.80439921CS
260-12.11-89.109639440813.5931.990.9551767194.27595852CS

BDSX - Frequently Asked Questions (FAQ)

What is the current Biodesix share price?
The current share price of Biodesix is US$ 1.48
How many Biodesix shares are in issue?
Biodesix has 145,467,295 shares in issue
What is the market cap of Biodesix?
The market capitalisation of Biodesix is USD 215.29M
What is the 1 year trading range for Biodesix share price?
Biodesix has traded in the range of US$ 1.11 to US$ 2.21 during the past year
What is the PE ratio of Biodesix?
The price to earnings ratio of Biodesix is -4.13
What is the cash to sales ratio of Biodesix?
The cash to sales ratio of Biodesix is 4.39
What is the reporting currency for Biodesix?
Biodesix reports financial results in USD
What is the latest annual turnover for Biodesix?
The latest annual turnover of Biodesix is USD 49.09M
What is the latest annual profit for Biodesix?
The latest annual profit of Biodesix is USD -52.15M
What is the registered address of Biodesix?
The registered address for Biodesix is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Biodesix website address?
The website address for Biodesix is www.biodesix.com
Which industry sector does Biodesix operate in?
Biodesix operates in the MEDICAL LABORATORIES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
US$ 17.34
(0.00%)
276.91k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69.73
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.21
(0.00%)
4.84k
AACGATA Creativity Global
US$ 0.762551
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.34
(0.00%)
282.45k
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69.73
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.21
(0.00%)
4.84k
AACGATA Creativity Global
US$ 0.762551
(0.00%)
0
NXUNXU Inc
US$ 0.2434
(0.00%)
125.6M
WATTEnergous Corporation
US$ 0.4112
(0.00%)
65.68M
VINCVincerx Inc
US$ 0.194
(0.00%)
28.14M
INTZIntrusion Inc
US$ 2.16
(0.00%)
27.09M
HOLOMicroCloud Hologram Inc
US$ 2.40
(0.00%)
26.76M

BDSX Discussion

View Posts
PonkenPlonken PonkenPlonken 3 weeks ago
Mr Schuler is buying shares again
👍️0
tw0122 tw0122 2 months ago
Is selling $250 million in stock fro time to time on the downside.. Separately, Biodesix filed a registration statement to sell up to $250 million in securities from time to time.
👍️0
tw0122 tw0122 2 months ago
Lung diagnostics cancer revenues improving still has $33m cash $1.49 +'14%
👍️0
AJ Freely AJ Freely 1 year ago
$BDSX - Up 12%/ Current Price $1.34.
Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
👍️0
1hot toddy 1hot toddy 2 years ago
WOOOOOOW 130K SHARES BUY NOW 2.6 MIL SHARE BUY $

3 MILLION $ BUY $$$$$$$$$$$$$$$$$$$$$$
👍️0
Leg58 Leg58 2 years ago
Lots if potential but will public offering dilute price?
👍️0
Leg58 Leg58 2 years ago
Lots if potential but will public offering dilute price?
👍️0
subslover subslover 2 years ago
Earnings look good.
👍️0
subslover subslover 2 years ago
Earnings look good.
👍️0
MiamiGent MiamiGent 2 years ago
BDSX Has news this morning!

The contract covers the company’s entire lung diagnostic portfolio: Nodify XL2®, Nodify CDT®, VeriStrat®, GeneStrat® ddPCR, and GeneStrat NGS™ testing.

https://investors.biodesix.com/news-releases/news-release-details/biodesix-awarded-us-federal-supply-schedule-contract-its

https://stockcharts.com/h-sc/ui?s=BDSX
👍️0
carusso carusso 2 years ago
Not so much...
👍️0
crudeoil24 crudeoil24 2 years ago
LET'S GO BDSX !!!!!
👍️0
crudeoil24 crudeoil24 2 years ago
Biodesix to Participate in Two Upcoming Investor Conferences in September
6:00 am ET September 6, 2022 (BusinessWire) Print
Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences:

Morgan Stanley 20th Annual Global Healthcare Conference Date: Tuesday, September 13, 2022 at 9:10 a.m. ET Format: Fireside Chat and 1x1 meetings Location: Sheraton Hotel, New York, NY Details: The fireside chat will be webcast live and available for replay under "News & Events" in the Investors section of the Company's website at www.biodesix.com.

H.C. Wainwright 24th Annual Global Investment Conference Dates: September 12-14, 2022 Format: 1x1 meetings Location: Lotte New York Palace Hotel, New York, NY
👍️0
crudeoil24 crudeoil24 2 years ago
Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Company’s product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.
👍️0
Leg58 Leg58 2 years ago
US based company is quietly trending up. IMHO.
GLTA
👍️0

Your Recent History

NASDAQ
BDSX
Biodesix
LSE
56JX
Sthn.pac 4a1ba
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads